• Home
  • A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy.

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy.

Author List
Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ
Publication
Journal of the American Chemical Society
Publication ID (Profile URL)
https://researcherprofiles.org/profile/392961275
Publication Year
2015
PubMed ID
26561720
Publication Title
Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ. A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy. J Am Chem Soc. 2015 Dec 02; 137(47):14854-7.